MedPath

Immunoblotting and Goldmann-Witmer Coefficient for Ocular Toxoplasmosis

Completed
Conditions
Ocular Toxoplasmosis
Interventions
Procedure: Aqueous humour sampling
Registration Number
NCT03948750
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

Ocular toxoplasmosis (OT) is a common cause of posterior uveitis worldwide. The diagnosis of OT is based on clinical findings, but in most cases, laboratory tests are required to confirm the etiology, especially when other diseases are suspected. The aim of this study was to evaluate which methods, between the Goldmann-Witmer coefficient (GWC) and immunoblotting (IB) with both IgG and IgA, in aqueous humour (AH) samples, can be the most sensitive to diagnose OT, in current practice, especially in the first three weeks.

Detailed Description

Goldmann-Witmer coefficient (GWC): compares the levels of intraocular antibody (igG) production to that serum, as measured by ELISA.

GWC = (Level of specific IgG in aqueous humour/level of specific IgG in serum)/(Total IgG in aqueous humour/Total IgG in serum)

0.5 to 2: No intraocular antibody production, 2 to 4: Suggestive of intraocular antibody production, \> 4: Diagnostic of intraocular antibody production to a specific microbial pathogen

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
87
Inclusion Criteria
  • Patients who had underwent aqueous humor and serum sample for ocular toxoplasmosis diagnosis
Read More
Exclusion Criteria
  • Immunocompromised patients
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients with Ocular ToxoplasmosisAqueous humour sampling-
Patients without Ocular ToxoplasmosisAqueous humour sampling-
Primary Outcome Measures
NameTimeMethod
Comparison of Goldmann-Witmer coefficient and immunoblotting resultsAssessment of each test result at the inclusion of the patient

All tests realized in patients were performed before their repartition in the two groups as well as the biologist could not know the status of the patient. Sensitivity and specificity were calculated for each test.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Service d'ophtalmologie, Hôpital de la Croix-Rousse (HCL)

🇫🇷

Lyon, France

© Copyright 2025. All Rights Reserved by MedPath